Low Progesterone Receptor Expression Is Associated with Distant Metastasia in Estrogen Receptor Positive/HER2 Negative and Lymph Node Negative Breast Cancer

被引：0
|
作者：
Mendoza, Pia
Sonmez, Ceyda
Neely, Cameron
Zhang, Chao
Liu, Yuan
Li, Xiaoxian
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
228
引用
收藏
页码：59A / 59A
页数：1
相关论文
共 50 条
  • [41] Analysis of estrogen receptor positive (ER+), progesterone receptor negative (PR-) phenotype and HER2 status in breast cancer (BC) patients
    Mitrovic, Slobodanka
    Stankovic, Vesna
    Azanjac, Goran
    Ninkovic, Srdan
    VIRCHOWS ARCHIV, 2007, 451 (02) : 299 - 299
  • [42] Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?
    Corti, Chiara
    De Angelis, Carmine
    Bianchini, Giampaolo
    Malorni, Luca
    Giuliano, Mario
    Hamilton, Erika
    Jeselsohn, Rinath
    Jhaveri, Komal
    Curigliano, Giuseppe
    Criscitiello, Carmen
    CANCER TREATMENT REVIEWS, 2023, 117
  • [43] Predictors of Response to Standard Neoadjuvant Chemotherapy in Estrogen Receptor Positive, HER2 Negative Breast Cancer
    Bhargava, R.
    LABORATORY INVESTIGATION, 2012, 92 : 26A - 26A
  • [44] Predictors of Response to Standard Neoadjuvant Chemotherapy in Estrogen Receptor Positive, HER2 Negative Breast Cancer
    Bhargava, R.
    MODERN PATHOLOGY, 2012, 25 : 26A - 26A
  • [45] HER2, estrogen receptor and progesterone receptor status in primary breast carcinomas and paired axillary lymph node metastases
    Desonki, M. M.
    Wolff, D. J.
    Geradis, J.
    Self, S. E.
    LABORATORY INVESTIGATION, 2008, 88 : 28A - 28A
  • [46] HER2, estrogen receptor and progesterone receptor status in primary breast carcinomas and paired axillary lymph node metastases
    Desonki, M. M.
    Wolff, D. J.
    Geradts, J.
    Self, S. E.
    MODERN PATHOLOGY, 2008, 21 : 28A - 28A
  • [47] Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer
    Van Asten, Kathleen
    Slembrouck, Laurence
    Olbrecht, Siel
    Jongen, Lynn
    Brouckaert, Olivier
    Wildiers, Hans
    Floris, Giuseppe
    Van Limbergen, Erik
    Weltens, Caroline
    Smeets, Ann
    Paridaens, Robert
    Giobbie-Hurder, Anita
    Regan, Meredith M.
    Viale, Giuseppe
    Thurlimann, Beat
    Vergote, Ignace
    Christodoulou, Evangelia
    Van Calster, Ben
    Neven, Patrick
    ONCOLOGIST, 2019, 24 (02): : 165 - 171
  • [48] Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2 negative breast cancer
    Yoder, Rachel
    Kimler, Bruce F.
    Staley, Joshua M.
    Schwensen, Kelsey
    Wang, Yen Y.
    Finke, Karissa
    O'Dea, Anne
    Nye, Lauren
    Elia, Manana
    Crane, Gregory
    McKittrick, Richard
    Pluenneke, Robert
    Madhusudhana, Sheshadri
    Beck, Larry
    Rodriguez, Roberto
    Shrestha, Anuj
    Corum, Larry
    Marsico, Mark
    Godwin, Andrew K.
    Khan, Qamar
    Sharma, Priyanka
    CANCER RESEARCH, 2021, 81 (04)
  • [49] Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
    Chansub Park
    Kyeongmee Park
    Jiyoung Kim
    Youngjoo Sin
    Inseok Park
    Hyunjin Cho
    Keunho Yang
    Byung Noe Bae
    Ki Whan Kim
    Sookyung Ahn
    Geumhee Gwak
    World Journal of Surgical Oncology, 14
  • [50] Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
    Park, Chansub
    Park, Kyeongmee
    Kim, Jiyoung
    Sin, Youngjoo
    Park, Inseok
    Cho, Hyunjin
    Yang, Keunho
    Bae, Byung Noe
    Kim, Ki Whan
    Ahn, Sookyung
    Gwak, Geumhee
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
12345